Brief: Clearside Biomedical Inc - All Employees To Transition To Consulting Roles - SEC Filing
17/07/2025 12:59
Clearside Biomedical Inc CLSD.O: CLEARSIDE BIOMEDICAL INC - ALL EMPLOYEES TO TRANSITION TO CONSULTING ROLES - SEC FILING CLEARSIDE BIOMEDICAL INC - ESTIMATES $3.4 MILLION IN TERMINATION COSTS - SEC FILING CLEARSIDE BIOMEDICAL INC: REDUCTION IN FORCE IS EXPECTED TO BE COMPLETED DURING Q3 OF 2025 Source text: [ID:n0000950170-25-096438] Further company coverage: CLSD.O
Recent news on Clearside Biomedical,
See all newsBrief: Clearside Biomedical Completes Financial Restructuring And Emerges From Chapter 11 With Steel Partners As Plan Sponsor
U.S. STOCKS ON THE MOVE-Merck, Genco, Tesla
U.S. STOCKS ON THE MOVE-Morgan Stanley, Merck, Genco
Clearside Biomedical plunges after filing for Chapter 11 bankruptcy
U.S. STOCKS ON THE MOVE-Bristol Myers Squibb, Palo Alto Networks, MP Materials